Â鶹ÊÓƵ

The Colorado Sun—Before Colorado was named a quantum Tech Hub, an ecosystem existed with roots dating back to the 1950s. Now, a push to commercialize quantum.

Through the Lab Venture Challenge (LVC), top innovations from CU Boulder, Denver and Colorado Springs compete for grants of up to $125,000. LVC supports projects that address a commercial need, have a clear path to a compelling market and have strong scientific support. These grants are funded by Venture Partners at CU Boulder and the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Program.

CU Boulder Today—Leaders from Colorado’s growing quantum ecosystem convened on campus last week to roll up their sleeves and begin mapping out a roadmap for workforce development in this new and growing field.

BizWest—SomaLogic Inc., a CU Boulder spinout, and California-based Standard BioTools Inc. have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion.

ArchDaily—Prometheus Materials, a CU Boulder spinout inspired by nature, aims to revolutionize the concrete industry by producing zero-carbon bio-cement and bio-concrete. This innovative approach harnesses microalgae to create sustainable building materials, reducing carbon emissions and addressing construction's environmental impact.

CU Boulder and Ball Aerospace have been collaborating for decades to solve mysteries of the universe. That partnership was also the university’s first commercial spin-off and it greased the gears of an entrepreneurial engine that continues to power innovation within the university and far beyond.

The Verge—To clean up some of the pollution stemming from its supply chain and data centers, Microsoft is experimenting with new kinds of concrete. In Quincy, Washington, they're working to reduce those emissions with CU Boulder startup Minus Materials with a process using algae to make the limestone used and capture CO2.

Pulse 2.0—CU Boulder startup BioLoomics, the company pioneering the directed evolution of target degrading antibodies using human cells, recently announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs.

BizWest—BioLoomics Inc., a CU Boulder spinout, has raised $8.7 million in seed financing. BioLoomics is a preclinical-stage biotechnology company pioneering directed evolution of target-degrading antibodies using human cells.

Forbes—Prometheus Materials, a CU Boulder spinout, has a solution for replacing one of the biggest contributors of greenhouse gasses, financial backing from Microsoft and an aggressive plan to scale up quickly.